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Abstract
Background
Sepsis morbidity and mortality rates have remained high despite recent developments in clinical guidelines
aimed to curtail this disease process. Understanding how sepsis interacts with comorbidities and preexisting disease states is necessary for improving sepsis treatment. Accounting for specific pre-existing
conditions in the treatment of sepsis patients may not only improve patient outcomes but also reduce
healthcare costs by preventing possible complications. We sought to evaluate whether the presence of
hypothyroidism affects outcomes in septic patients.

Methods
In this retrospective observational study, we analyzed the patient dataset from a not-for-profit rural hospital
from January 2019 through June 2020. We chose the initial patient sample based on International
Classification of Disease (ICD10) codes for sepsis. We then used the ICD10 code for hypothyroidism within
that sample to identify the septic patients with hypothyroidism. We did two-sample proportion summary
hypothesis tests to identify differences in mortality and 30-day readmission rates.

Results
In our dataset, we had 1,122 patients with sepsis, of whom 225 had hypothyroidism. There was no difference
in sepsis outcomes between patients who had hypothyroidism compared to patients who did not have
hypothyroidism. Additionally, we did not find sufficient evidence to conclude that the patient’s sex affects
sepsis outcomes in hypothyroid patients.

Conclusion
Within this Midwest population, the sepsis outcomes were not impacted by having hypothyroidism as a
secondary diagnosis. Additionally, there was no sufficient evidence to suggest an impact on sepsis outcomes
based on sex, either male or female, when considering concomitant hypothyroidism.

Categories: Emergency Medicine
Keywords: midwest, sex, mortality, hypothyroidism, sepsis

Introduction
Hypothyroidism is defined as having a thyroid gland disorder that leads to a decreased synthesis of thyroid
hormones [1]. The National Health and Nutrition Examination Survey (NHANES III) reported that 4.6% of
the US population has hypothyroidism [2]. The prevalence of hypothyroidism depends on many factors, with
race and sex being the most significant ones. White and Mexican Americans are the most affected [2]. When
evaluating sex, it has been shown that females are more commonly affected than males, specifically in the
age groups 50-59 and 60-69 [2]. The clinical symptoms of hypothyroidism are non-specific and not helpful
for diagnosis. Patients have complained of fatigue, weight gain, and hair loss, all of which can be symptoms
of other diseases. The American Thyroid Association recommends that both sexes be screened every five
years, starting at age 35 [3]. Yet, 13 million Americans have undiagnosed hypothyroidism, making it an
important field of study [4]. The severity of symptoms correlates with dysfunction. However, elderly patients
tend to experience less severe symptoms [1,5]. The overall mortality risk caused by hypothyroid disease
remains uncertain.
Similar to hypothyroidism, sepsis affects a wide variety of people. Those at a higher risk of developing
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infections may also be at a higher risk of developing sepsis. This includes the very young, the very old, those
with weakened or impaired immune systems, and those with chronic illnesses such as HIV or cancer. Sepsis
is a common medical emergency, with 1.7 million Americans developing it every year [6]. An observational
study found that sepsis causes as many deaths annually as acute myocardial infarction. The same study
estimated that the incidence of sepsis would increase annually by 1.5% [7]. The population of people
developing sepsis is very diverse. However, epidemiological studies have looked at many potential risk
factors for sepsis. Martin et al. investigated race and found a higher incidence in African Americans, and
Barnato et al. described a low incidence in Hispanics [8,9]. When looking at age, sepsis incidence increases
slowly in people aged 60-64 and starts to increase rapidly in people over 85 years old [7]. Sex has been found
to discriminate against sepsis as well. When age is adjusted, females have a lower risk of developing sepsis
[7,10]. It was found that differences in the immune system attribute to a better prognosis for females in
surgical septic patients [11]. There are conflicting results as to whether sex has an impact on mortality.
However, females had a higher rate of mortality when looking at ICU admitted patients with severe sepsis
[11].
Previous studies have shown that patients with sepsis will develop hypothyroidism secondary to the
infectious process and the body's compensatory response [12,13]. However, there is a gap in knowledge
regarding how patients diagnosed with hypothyroidism respond to sepsis in terms of mortality and
readmission outcomes. The purpose of this study is to compare the mortality outcomes of septic patients
with and without hypothyroidism to see if there is a difference. Given the sex disparities in sepsis and
hypothyroidism, we also wanted to analyze patients based on sex and whether having hypothyroidism
affects their sepsis outcome. This paper serves to help fill the gap in our understanding of the sepsis disease
process in hypothyroid patients and provide clinicians with empirical data that can be used to help tailor the
treatment of patients with hypothyroidism in the future.

Materials And Methods
This retrospective observational study was designed to investigate the impact of hypothyroidism on sepsis
outcomes and analyze outcomes using sex as a variable. The study was approved by the Institutional Review
Board of Freeman Health System under the protocol title: The Surviving Sepsis Campaign and its Effect on
Patient Populations with Sepsis and Pre-existing Comorbidities. Due to its retrospective nature, informed
consent was not required. We collected a patient dataset from the electronic medical records system of
Freeman Health System, a not-for-profit rural hospital located in Joplin, MO, from January 2019 to June
2020. We chose our initial patient sample using International Classification of Disease (ICD10) diagnosis
codes for sepsis listed in Table 1, which yielded 1,122 patients. Using hypothyroidism ICD10 code E03.9, we
identified all patients in our initial sample who had hypothyroidism, unspecified, as a secondary diagnosis.
This resulted in 225 patients leaving, and 897 patients who did not. In the hypothyroidism group, there were
143 females and 82 males (Table 2). We used two-sample proportion summary hypothesis tests to compare
mortality and 30-day readmission rates between the hypothyroidism patient group and the nonhypothyroidism patient group, looking at sex as a variable. For patients in the hypothyroidism group, we
used sex as a variable to compare mortality rates only. Data was insufficient for age category comparisons
and further addressed in the limitations. Although our purpose was to analyze whether sex makes a
difference in sepsis outcome, we did also compare males to females in the hypothyroidism group and nonhypothyroidism group, and no significance was detected.
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ICD-10 Code

Diagnosis

A400

Sepsis due to Streptococcus, group A

A401

Sepsis due to Streptococcus, group B

A403

Sepsis due to Streptococcus pneumonia

A408

Other streptococcal sepsis

A409

Streptococcal sepsis, unspecified

A4101

Sepsis due to methicillin susceptible S. aureus

A4102

Sepsis due to methicillin resistant S. aureus

A411

Sepsis due to other specified Staphylococcus

A412

Sepsis due to unspecified Staphylococcus

A413

Sepsis due to Haemophilus influenza

A414

Sepsis due to anaerobes

A4150

Gram-negative sepsis, unspecified

A4151

Sepsis due to Escherichia coli (E. coli)

A4152

Sepsis due to Pseudomonas

A4153

Sepsis due to Serratia

A4159

Other gram-negative sepsis

A4181

Sepsis due to Enterococcus

A4189

Other specified sepsis

A419

Sepsis, unspecified organism

TABLE 1: ICD10 inclusion criteria for all patients.
ICD: International Classification of Disease.
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Patient group

Number of patients

Sepsis
Male

574

Female

548

Total

1,122

Sepsis and hypothyroidism
Male

82

Female

143

Total

225

Age and hypothyroidism
18-39 Male

0

18-39 Female

1

40-64 Male

26

40-64 Female

38

65+ Male

56

65+ Female

104

TABLE 2: Patient sample groups.

Results
From our total sepsis dataset, a total of 225 septic patients (20%) had hypothyroidism as a secondary
diagnosis. Using a two-sample proportion summary hypothesis test, we found no significant difference in
mortality or 30-day readmission rate outcomes when comparing the total hypothyroid septic group to the
total non-hypothyroid septic group (Table 3, p-value <0.05 used). Results were also insignificant when
comparing sex within the two groups to one another (Table 4). No evidence was observed that indicates sex
influences sepsis mortality outcomes in patients with a secondary diagnosis of hypothyroidism (Table 4).

Populations

Difference

Count 1

Total 1

Count 2

Total 2

Sample difference

Std. err.

Z-stat

P-value

Male

p1−p2

16

82

107

492

−0.022,357,724

0.048,943,543

−0.456,806,4

0.647,8

Female

p1−p2

39

143

84

405

0.065,319,865

0.040,584,595

1.609,474,4

0.107,5

Total

p1−p2

55

225

191

897

0.031,512,449

0.030,848,617

1.021,519

0.307

Mortality

30-Day readmission
Male

p1−p2

13

83

55

492

0.046,747,967

0.038,546,441

1.212,77

0.225,2

Female

p1−p2

21

143

50

405

0.023,396,357

0.032,666,496

0.716,218,74

0.473,9

Total

p1−p2

34

225

105

897

0.034,054,255

0.024,564,066

1.386,344,4

0.165,6

TABLE 3: Comparison of mortality and 30-day readmission of hypothyroid patients to nonhypothyroid.
Two sample proportion summary hypothesis test. p1 : proportion of successes for hypothyroid population, p2: proportion of successes for non-hypothyroid
population, p1−p2: difference in proportions, H0: p1−p2 = 0, HA: p1−p2 ≠ 0. HA: alternative hypothesis; Std. err: standard of error; Z-stat: standard score.
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Population

Difference

Count 1

Total 1

Count 2

Total 2

Sample difference

Std. err.

Z-stat

P-value

Total

p1−p2

39

143

16

82

0.077,605,32

0.059,530,51

1.303,622,7

0.192,4

TABLE 4: Comparison of mortality in female hypothyroid patients to male hypothyroid patients.
Two sample proportion summary hypothesis test. p1: proportion of successes for female population, p2: proportion of successes for male
population, p1−p2: difference in proportions, H0: p1−p2 = 0, HA: p1−p2 ≠ 0. HA: alternative hypothesis; Std. err: standard of error; Z-stat: standard score.

Discussion
In this study, we first wanted to analyze whether having hypothyroidism as a secondary diagnosis impacts
outcomes in patients with sepsis. When looking at mortality and 30-day readmission rate, we found these
outcomes were not impacted by a secondary hypothyroidism diagnosis. In our hypothyroid population, we
had 143 females (64%) and 82 males (36%) (Table 2). This difference, as well as past studies that have
implicated sex as having an effect on both hypothyroidism and sepsis individually, led us to investigate the
effect of sex in septic patients with hypothyroid disease. Our results suggest that sex, at least for our sample
group, does not affect sepsis outcomes in patients with hypothyroidism. Despite the fact that for both
diseases, sepsis and hypothyroidism, females have been shown to be more commonly affected. However,
having both did not impact the outcomes for the specific sample group investigated. Our results do not mean
there are no differences. However, none were found in this sample using the statistical tests performed.
There may or may not be a difference for the general population as a whole.

Conclusions
The current study revealed that septic patients with hypothyroidism do not have statistically significant
differences in mortality or 30-day readmission outcomes when compared to septic patients who do not have
hypothyroidism. In addition, we found no statistically significant differences in mortality outcomes based
on sex in septic patients with hypothyroidism. Further studies should include age as a variable in the
analysis as well as focus on a population that is relatively homogenous in terms of medical
history. Additionally, a multi-center study would be able to achieve generalizable results compared to our
single-center retrospective study. Due to the retrospective nature of this study, we did not have access to the
patient’s hypothyroidism diagnosis and management. Further studies should categorize hypothyroidism
into different types, such as primary or subclinical hypothyroidism, to see if sepsis is influenced by having a
specific type of hypothyroidism. Besides diagnostic classifications, it would be beneficial to know the
patient’s treatment plan to evaluate how well the hypothyroidism is controlled and compare sepsis
outcomes based on mild, moderate, or severe secondary diagnosis.

Limitations
Our sample groups come from a not-for-profit rural hospital located in Southwest Missouri that serves the
four-state area of Arkansas, Kansas, Oklahoma, and Missouri. Because of this, our results may not apply to
other populations outside of the Midwest, including urban or suburban populations. Our population was not
randomly selected and had a low sample size overall. There was great variability between the sizes of our
two groups, with our hypothyroid group being almost four times smaller than our non-hypothyroid group.
We selected our initial sepsis sample group for severe illness and ICD10 codes specific to sepsis, which were
charted at the patient’s visit. The ICD10 for hypothyroidism was charted as a new diagnosis at the same visit.
Hence, our sample population was not randomly selected and may not be representative of their respective
populations as a whole. It is also important to note that our patient population is heterogeneous, as they
likely have multiple other diseases, including various secondary comorbidities affecting their health and
overall septic outcome. These confounding variables were not considered in our analysis. Hence, it is valid
to assume that the other comorbidities could have played a significant role in this group’s patient sepsis
outcomes, but their analysis is outside of this study. Our data set did not allow us to define a personal
history of hypothyroidism as patient charts and secondary comorbidities listed were specific to the original
screen for sepsis ICD10 codes (Table 1). It is assumed all patients screened using ICD10 code E03.9 would
have received that diagnosis upon the patients visit for sepsis. We did not have access to the patient’s
medical history. Due to the retrospective nature of this study, we did not have the ability to further
categorize hypothyroidism based on type, treatment plan, or severity. We were unable to obtain any
medication profiles from our patients. Hence, we were unable to determine how well their hypothyroidism
was being managed and what the severity is. In addition, electronic medical records did not include any lab
work or screening results for subcategories such as Euthyroid sick syndrome, subclinical hypothyroidism, or
medications. This means we did not have access to the type of hypothyroidism, what medications they were
taking, or how long they had been treated for it. Although myxedema is included in the ICD10 codes for
hypothyroidism, we do not know which patient had it. As a result, we were unable to further classify our
patients into specific categories. Additionally, our patients were categorized into the age groups of 18-39,
40-64, and 65 or greater (Table 2). However, we did not have an equal number of patients in each age group.
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Thus, for our analysis, we did not use age as a variable for outcomes. Therefore, it is unclear if age as a
variable would have changed our results.

Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Institutional Review
Board of Freeman Health System issued approval 2021002. The study was approved by the Institutional
Review Board of Freeman Health System under the protocol title: The Surviving Sepsis Campaign and its
Effect on Patient Populations with Sepsis and Pre-existing Comorbidities. Due to its retrospective nature,
informed consent was not required. Animal subjects: All authors have confirmed that this study did not
involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure
form, all authors declare the following: Payment/services info: All authors have declared that no financial
support was received from any organization for the submitted work. Financial relationships: All authors
have declared that they have no financial relationships at present or within the previous three years with
any organizations that might have an interest in the submitted work. Other relationships: All authors have
declared that there are no other relationships or activities that could appear to have influenced the
submitted work.
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